Literature DB >> 1912525

Tumor cell adhesive mechanisms and their relationship to metastasis.

J B McCarthy1, A P Skubitz, J Iida, D L Mooradian, M S Wilke, L T Furcht.   

Abstract

Despite recent advances in the diagnosis and therapy of many forms of cancer, metastasis remains the major cause of death in cancer patients. As tumors progress they become increasingly heterogeneous, giving rise to aggressive subpopulations of tumor cells that subsequently invade local tissues, the lymphatics, and the circulatory system. This invasive behavior can ultimately lead to the widespread dissemination and metastasis of the primary tumor. In hematogenous metastasis, emboli consisting of tumor cells, host cells, platelets, and fibrin are transported to distant sites where they arrest in the microvasculature prior to extravasation. It is well accepted that tumor cell adhesion plays a fundamental role in many of the stages of the metastatic process. Tumor cell interactions with extracellular matrix components of tissue, tissue boundaries (basement membranes), or cell adhesion-promoting components of plasma; influence tumor cell motility, invasiveness, and many other important aspects of the metastatic tumor cell phenotype. Tumor cell adhesion also has a rate-limiting influence at various stages within the metastatic process, such as tumor cell arrest and extravasation. In addition, the ability of the immune system to recognize and successfully eradicated tumors is also highly dependent on the adhesion of activated lymphocytes to target tumor cells. Despite the rapid accumulation of information on the molecular basis of cell adhesion, our understanding of the relationship between tumor cell adhesion and hematogenous metastasis per se is fragmented and incomplete. Nevertheless, clear progress has been made, both in understanding the molecular basis of tumor cell adhesion and its relationship to the biology of tumor metastasis. New and exciting directions have been identified that are likely to yield direct benefits in developing new therapeutic or diagnostic approaches for malignant neoplasms. Our purpose is to briefly review the molecular basis of tumor cell adhesion from the standpoint of many of the receptors involved as well as their putative ligands. The relationship between specific tumor cell adhesion events and the formation of metastatic lesions is also addressed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1912525

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  13 in total

1.  The differential effect of endothelial cell factors on in vitro motility of malignant and non-malignant cells.

Authors:  Adele Wright; Yu-Hua Li; Cheng Zhu
Journal:  Ann Biomed Eng       Date:  2008-04-09       Impact factor: 3.934

2.  Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.

Authors:  T Akimoto; S Kawabe; A Grothey; L Milas
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

3.  Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behaviour.

Authors:  W G Horstmann; W Timens
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

Review 4.  Tumor cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumor cell motility, invasion and metastasis.

Authors:  B R Lester; J B McCarthy
Journal:  Cancer Metastasis Rev       Date:  1992-03       Impact factor: 9.264

5.  The role of beta 1 integrins in adhesion of two breast carcinoma cell lines to a model endothelium.

Authors:  R D Bliss; J A Kirby; D A Browell; T W Lennard
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

6.  Integrins and extracellular matrix-proteins in the different components of the Wilms' tumour.

Authors:  J Peringa; W M Molenaar; W Timens
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

Review 7.  Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy.

Authors:  W T Chen; C C Lee; L Goldstein; S Bernier; C H Liu; C Y Lin; Y Yeh; W L Monsky; T Kelly; M Dai
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 8.  Tumor invasion, proteolysis, and angiogenesis.

Authors:  U P Thorgeirsson; C K Lindsay; D W Cottam; D E Gomez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

9.  Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components.

Authors:  E Ioachim; M C Michael; M Salmas; K Damala; E Tsanou; M M Michael; V Malamou-Mitsi; N E Stavropoulos
Journal:  BMC Cancer       Date:  2006-05-29       Impact factor: 4.430

10.  Induction of tumour cell shedding into effluent venous blood breast cancer surgery.

Authors:  A Choy; P McCulloch
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.